Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001723128-19-000095
Filing Date
2019-05-13
Accepted
2019-05-13 17:27:41
Documents
1
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155778284616883.html 4  
1 FORM 4 wf-form4_155778284616883.xml 4 3679
  Complete submission text file 0001723128-19-000095.txt   5046
Mailing Address C/O WATSON PHARMA INC 360 MOUNT KEMBLE AVE MORRISTOWN NJ 07960
Business Address
BOYER ANDREW S (Reporting) CIK: 0001239546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 19819568

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations